Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: albuterol sulfate

« Back to Dashboard
Albuterol sulfate is the generic ingredient in fourteen branded drugs marketed by Teva Branded Pharm, 3M, Glaxosmithkline, Mylan Speclt, Actavis Mid Atlantic, Apotex Inc, Bausch And Lomb, Copley Pharm, Hi Tech Pharma, Landela Pharm, Nephron, Ritedose Corp, Roxane, Teva Pharms, Watson Labs, Watson Labs Inc, Wockhardt Eu Operatn, Schering, Amneal Pharms, Mova, Teva, Vintage, Vistapharm, Mylan, Muro, Dava Pharms Inc, Am Therap, Mutual Pharm, Pliva, Sandoz, Ucb Inc, Warner Chilcott, Boehringer Ingelheim, Cipla Ltd, and Sandoz Inc, and is included in eigthy-two NDAs. There are fourty-four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for albuterol sulfate. Eighteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: albuterol sulfate

Tradenames:14
Patents:44
Applicants:35
NDAs:82
Drug Master File Entries: see list34
Suppliers: see list18
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: albuterol sulfate

Tentative approvals for ALBUTEROL SULFATE

Applicant Application No. Form Dosage
<disabled><disabled>POWDER;INHALATION90MCG

Clinical Trials for: albuterol sulfate

Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning
Status: Not yet recruiting Condition: Salbutamol; Organophosphate Poisoning; Atropine

Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction
Status: Terminated Condition: Asthma; Bronchospasm

Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
Status: Completed Condition: Airway Disease; Asthma; Acute Wheezing

Salbutamol, Pharmacogenetics and Breathing Mechanics
Status: Active, not recruiting Condition: Exercise-induced Bronchoconstriction,; Inhaled Salbutamol; Cycling Performance

Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
Status: Completed Condition: Healthy Volunteers

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
Status: Completed Condition: Asthma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001RXYes6,938,796*PED<disabled>Y<disabled>
Copley Pharm
ALBUTEROL SULFATE
albuterol sulfate
SOLUTION;INHALATION073307-001Nov 27, 1991DISCNNo<disabled><disabled>
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001RXYes7,832,351*PED<disabled>Y<disabled>
Boehringer Ingelheim
COMBIVENT RESPIMAT
albuterol sulfate; ipratropium bromide
SPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYes7,896,264<disabled>Y<disabled>
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001RXYes6,743,413*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc